Navigation Links
Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
Date:8/16/2012

THE WOODLANDS, Texas, Aug. 16, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, today reported preliminary results from Phase 1 studies of LX2931 and LX7101.

The Phase 1 study of LX2931, an inhibitor of sphingosine-1-phosphate lyase, was a dose-ranging study to explore higher doses of LX2931 in patients with rheumatoid arthritis. The study involved 10 patients with rheumatoid arthritis, eight of whom were randomized to LX2931 and two to placebo.  The primary endpoint in the study was an evaluation of the safety and tolerability of escalating doses of LX2931 compared with placebo over 12 weeks in subjects with active rheumatoid arthritis.  Secondary endpoints included pharmacokinetic and disease activity measures. 

Patients in the study received increasing doses over the course of the study, beginning at 50 mg QD and escalating to 500 mg QD.  LX2931 was well-tolerated at all doses evaluated, with no serious adverse events and no withdrawals due to adverse events. Seven of eight patients on LX2931 achieved drug trough levels greater than 60 ng/ml, a pharmacokinetic measure which a post-hoc analysis of data from a prior Phase 2 study of LX2931 had suggested was associated with better responses in American College of Rheumatology (ACR) measures in the study.  Six of the eight LX2931-treated patients experienced a drop from baseline in the DAS28 score of greater than or equal to 1.2, as did both placebo patients.  ACR20 and ACR50 responses were achieved at varying frequencies in both LX2931-treated and placebo patients, but two of eight patients dosed with LX2931 achieved an ACR70 response during the course of the study,
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
3. Lexicon to Provide Second Quarter 2012 Financial Results
4. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
5. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
6. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
7. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
8. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
10. Lexicon to Provide First Quarter 2012 Financial Results
11. Nouveau Life Pharmaceuticals (NOUV) Releases Calcium & Vitamin D for Strong Bones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... NEW YORK , Aug. 28, 2014 /PRNewswire/ ... report is available in its catalogue: ... to 2020 http://www.reportlinker.com/p02343442/Germany-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Market Outlook to 2020 Summary GlobalData,s ... Market Outlook to 2020", provides key market data ...
(Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- EDGE Orthopaedics, a ... is excited to announce they have received their ... System and REDUCE Fracture Plating System. ... to support multiple indications within the mid-foot. The ... Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular (TN) and Evans ...
(Date:8/28/2014)... CITY , Aug. 28, 2014 /PRNewswire-iReach/ -- Academy ... by service academy graduates, has published a case ... three-day Leadership Excellence Course . In September and ... Excellence Course to Albuquerque , Indianapolis ... . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
Breaking Medicine Technology:Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9EDGE Orthopaedics Receives Second FDA Clearance 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5
... March 25, 2011 Soles4Souls, the international shoe charity ... their proceeds from orders to Soles4Souls, to help provide ... 9.0 magnitude earthquake that rocked Japan on March 9, ... Pharmacy; call 877-323-9803 for your prescriptions, medical supplies, and ...
... AssureRx Health, Inc. today announced the closing ... medicine company, which provides clinically-relevant information to help physicians ... individual neuropsychiatric patients, will use the funds to expand ... GeneSightRx®, and for second generation product development activities. ...
Cached Medicine Technology:PromiseCare Pharmacy Donates to Soles4Souls® Japanese Relief Efforts 2AssureRx Health Raises $11 Million Series B Financing 2AssureRx Health Raises $11 Million Series B Financing 3AssureRx Health Raises $11 Million Series B Financing 4
(Date:8/28/2014)... (PRWEB) August 28, 2014 Valero Renewable ... Energy Corporation (NYSE: VLO), and the Ports of Indiana ... local officials today at a Port Appreciation and Welcome ... Vernon ethanol plant. , “The opening of Valero’s ethanol ... is another economic development win for the State of ...
(Date:8/28/2014)... Gurnick Academy of Medical Arts is proud ... for the 5 years of the accreditation cycle by ... , “We are very proud to have earned the ... make sure we provide the best experience to our ... field nowadays and I look forward to see more ...
(Date:8/28/2014)... Amy Norton HealthDay Reporter ... found that sending electrical currents through the scalp to a ... up to a day. In a small study of ... fire up certain networks involved in memory. That, in turn, ... 24 hours after the brain stimulation. During TMS, an ...
(Date:8/28/2014)... is "stuck fermentation," when yeast that should be busily ... shuts down, leaving the remaining sugar to instead be ... A team of researchers including UC Davis yeast geneticist ... this problem. Working through a prion -- an ... system enables bacteria in fermenting wine to switch yeast ...
(Date:8/28/2014)... Data from the American Hospital Association’s 2013 ... utilize a basic electronic health record (EHR) system, more ... a challenge. , This data is featured in ... Affairs , and is co-authored by Peter Kralovec, executive ... well as Chantal Worzala, director for policy at the ...
Breaking Medicine News(10 mins):Health News:Valero, Ports of Indiana Celebrate Restart of Ethanol Plant 2Health News:Valero, Ports of Indiana Celebrate Restart of Ethanol Plant 3Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2Health News:Electrical Pulses to Scalp May Boost Memory: Study 2Health News:Electrical Pulses to Scalp May Boost Memory: Study 3Health News:Prions can trigger 'stuck' wine fermentations, researchers find 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 3
... Pulmonary Fibrosis (CPF) today announced the launch of its newly ... fibrosis (PF), a devastating and ultimately fatal disorder characterized by ... Americans. Prevalence and incidence of PF has increased more ... each year - the same number as breast cancer. , ...
... and cabbage works by lowering the activity of an ... a University of California, Berkeley, study appearing this week ... Proceedings of the National Academy of Sciences . , ... humans because it was found to stop the growth ...
... of The Balm In Gilead, joined Rick Warren, pastor of ... leaders at a,Civic Forum on Global Health for a World ... Laura Bush,s leadership in addressing,HIV around the globe. , ... State of the Union address that President Bush pledged,to address ...
... Link IT Hurdles to Missed or Delayed Diagnosis;,Almost Seventy Percent Report ... ... 3, 2008 -- A national survey released today (at RSNA ... hindering radiologists, ability to control skyrocketing demand and negatively impacting patient ...
... Tibotec Pharmaceuticals today,announced that it has signed ... of India to distribute the protease,inhibitor darunavir (DRV) ... Tibotec is committed to ensuring access to ... of the company,s strong reputation in,India and extensive ...
... Cardium Therapeutics,(Amex: CXM ) announces that ... investor presentation, corporate update and review of its ... be presented following the close of,market today at ... at, http://www.investorcalendar.com/IC/CEPage.asp?ID=138418 at that time. The,webcast ...
Cached Medicine News:Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 2Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 3Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 4Health News:Broccoli compound targets key enzyme in late-stage cancer 2Health News:Broccoli compound targets key enzyme in late-stage cancer 3Health News:The Balm In Gilead Joins Saddleback Church in Thanking President Bush for His Leadership on Addressing HIV and AIDS Around the World 2Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 2Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 3Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 4Health News:Tibotec and Emcure Collaborate on Access to Darunavir for India 2Health News:Tibotec and Emcure Collaborate on Access to Darunavir for India 3Health News:Cardium Announces Investor Presentation and Corporate Update Webcast 2
... Multilok Hand Operating Table has exceptional ... and spatial positioning of fingers and ... of the hand, fingers and forearm. ... with re-usable base and single use ...
The Hydroflex Arthroscopic Irrigation Pump is simple to transport, set-up and tear down. The pump is streamlined with a simple control panel an no transducers or electronics to control flow. It is co...
... the Vortex Vacuum Mixer is clinically proven to ... traditional vacuum mixers. The ergonomically angled base means ... crank three revolutions every time you turn ... stirring, cutting down on the amount of air ...
... worked in partnership with clinicians for more ... of autologous blood to patients. With the ... new levels of simplicity while helping to ... in new levels of confidence for surgeons ...
Medicine Products: